2025 annual financial data
Atrium Therapeutics 2025 Operating margin
Direct answer
Operating margin was -412.58%.
Operating income was -76,814,000 USD and net income was -76,684,000 USD.
Operating cash flow was -41,129,000 USD.
Get free Atrium Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,618,000 USD
- Operating income
- -76,814,000 USD
- Net income
- -76,684,000 USD
- Operating cash flow
- -41,129,000 USD